Our top pick for
CSI Compressco LP is an oil & gas equipment & services business based in the US. CSI Compressco shares (CCLP) are listed on the NASDAQ and all prices are listed in US Dollars. CSI Compressco employs 730 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$1.56|
|52-week range||$0.74 - $2.32|
|50-day moving average||$1.60|
|200-day moving average||$1.64|
|Wall St. target price||$1.00|
|Dividend yield||$0.04 (2.53%)|
|Earnings per share (TTM)||$-1.29|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||N/A|
|1 month (2021-09-22)||N/A|
|3 months (2021-07-26)||0.65%|
|6 months (2021-04-26)||-15.68%|
|1 year (2020-10-26)||75.28%|
|2 years (2019-10-25)||-42.44%|
|3 years (2018-10-26)||4.76|
|5 years (2016-10-26)||11.12|
Valuing CSI Compressco stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CSI Compressco's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CSI Compressco's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.81. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CSI Compressco's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CSI Compressco's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $84.4 million.
The EBITDA is a measure of a CSI Compressco's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$278.8 million|
|Operating margin TTM||2.29%|
|Gross profit TTM||$127.4 million|
|Return on assets TTM||0.55%|
|Return on equity TTM||-532.2%|
|Market capitalisation||$74.8 million|
TTM: trailing 12 months
There are currently 157,590 CSI Compressco shares held short by investors – that's known as CSI Compressco's "short interest". This figure is 7.3% down from 169,981 last month.
There are a few different ways that this level of interest in shorting CSI Compressco shares can be evaluated.
CSI Compressco's "short interest ratio" (SIR) is the quantity of CSI Compressco shares currently shorted divided by the average quantity of CSI Compressco shares traded daily (recently around 59467.924528302). CSI Compressco's SIR currently stands at 2.65. In other words for every 100,000 CSI Compressco shares traded daily on the market, roughly 2650 shares are currently held short.
However CSI Compressco's short interest can also be evaluated against the total number of CSI Compressco shares, or, against the total number of tradable CSI Compressco shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CSI Compressco's short interest could be expressed as 0% of the outstanding shares (for every 100,000 CSI Compressco shares in existence, roughly 0 shares are currently held short) or 0.0061% of the tradable shares (for every 100,000 tradable CSI Compressco shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CSI Compressco.
Find out more about how you can short CSI Compressco stock.
We're not expecting CSI Compressco to pay a dividend over the next 12 months.
Over the last 12 months, CSI Compressco's shares have ranged in value from as little as $0.735 up to $2.3219. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CSI Compressco's is 1.4836. This would suggest that CSI Compressco's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CSI Compressco LP provides compression services for natural gas and oil production, gathering, artificial lift, transmission, processing, and storage companies in the United States, Mexico, Canada, Argentina, and internationally. The company offers GasJack and VJack electric powered low-horsepower compressor packages to provide production enhancement services for dry gas wells, liquid-loaded gas wells, and backside auto injection systems. It also provides medium-horsepower compressor packages to move natural gas from the wellhead through the field gathering system; and high-horsepower compressor packages for use in midstream applications, including natural gas gathering and centralized compression facilities. In addition, the company sells engine parts, compressor package parts, and other components manufactured by third-party suppliers, as well as provides aftermarket services, such as operations, maintenance, overhaul, and reconfiguration. Further, it offers well monitoring and sand separation, as well as early production services. CSI Compressco GP Inc. serves as the general partner of CSI Compressco LP.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.